November 02, 2011
Cephalon Inc. accused Breckenridge Pharmaceutical Inc. on Wednesday of infringing a patent for Nuvigil in its latest Delaware federal court attempt to keep generic-drug makers from selling versions of the narcolepsy drug before the patent expires.